25 years International Bladder Cancer Network (IBCN): The past, the present, and the future
Dyrskjøt L, Vlahou A, Black PC, Droller M, Grossmann HB, Goebell P, Kamat AM, Nawroth R, Seiler R, Todenhöfer T, Williams SB, Schmitz-Dräger BJ (2023)
Publication Type: Journal article, Review article
Publication year: 2023
Journal
Book Volume: 41
Pages Range: 302-306
Journal Issue: 7
DOI: 10.1016/j.urolonc.2022.10.031
Abstract
In 1997 an international group of scientists organized a meeting in Barcelona, Spain, to discuss the use of biomarkers in the management of patients with bladder cancer. This meeting was the offspring of an – initially informal – group that finally resulted in the foundation and incorporation of the International Bladder Cancer Network (IBCN) e.V. in 2005. Over the years the group has supported several research initiatives and generated several recommendations on the use of biomarkers in the diagnosis and treatment of bladder cancer. Meeting quality was generated by inviting experts presenting state-of-the-art lectures or work in progress reports, interdisciplinarity and the limited number of participants supporting an open and personal exchange resulted in a format increasingly attracting participants from all over the world. The recent limitations caused by the Covid-19 pandemic were partially met by organizing several well attended webinars. The future challenge is to maintain the IBCN meeting spirit despite an increasing interest of the scientific community and industrial partners to participate. However, the integration of and interaction between increasingly more specialized disciplines is a challenge that can be better catalyzed by an international multidisciplinary network than mostly national professional associations.
Authors with CRIS profile
Involved external institutions
University of British Columbia
Canada (CA)
Aarhus University
Denmark (DK)
University of Texas MD Anderson Cancer Center
United States (USA) (US)
Mount Sinai Hospital
United States (USA) (US)
Biomedical Research Foundation of the Academy of Athens (BRFAA) / Iδρυμα Ιατροβιολογικών Ερευνών της Ακαδημίας Αθηνών (ΙΙΒΕΑΑ)
Greece (GR)
Spitalzentrum Biel / Centre hospitalier Bienne
Switzerland (CH)
University of Texas Medical Branch (UTMB)
United States (USA) (US)
Klinikum rechts der Isar
Germany (DE)
Canada (CA)
Aarhus University
Denmark (DK)
University of Texas MD Anderson Cancer Center
United States (USA) (US)
Mount Sinai Hospital
United States (USA) (US)
Biomedical Research Foundation of the Academy of Athens (BRFAA) / Iδρυμα Ιατροβιολογικών Ερευνών της Ακαδημίας Αθηνών (ΙΙΒΕΑΑ)
Greece (GR)
Spitalzentrum Biel / Centre hospitalier Bienne
Switzerland (CH)
University of Texas Medical Branch (UTMB)
United States (USA) (US)
Klinikum rechts der Isar
Germany (DE)
How to cite
APA:
Dyrskjøt, L., Vlahou, A., Black, P.C., Droller, M., Grossmann, H.B., Goebell, P.,... Schmitz-Dräger, B.J. (2023). 25 years International Bladder Cancer Network (IBCN): The past, the present, and the future. Urologic Oncology-Seminars and Original Investigations, 41(7), 302-306. https://dx.doi.org/10.1016/j.urolonc.2022.10.031
MLA:
Dyrskjøt, Lars, et al. "25 years International Bladder Cancer Network (IBCN): The past, the present, and the future." Urologic Oncology-Seminars and Original Investigations 41.7 (2023): 302-306.
BibTeX: Download